세계의 개 아토피 피부염 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 투여 방법별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Mode of Administration, By Distribution Channel, By Region & Competition, 2020-2030F
상품코드:1692199
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 개 아토피 피부염 시장은 2024년에는 9억 9,560만 달러로 평가되었으며, 2024년부터 2030년까지 CAGR은 9.90%를 나타낼 전망입니다.
이 시장에는 개 아토피 피부염(가려움증, 염증, 불편함을 유발하는 일반적인 피부 질환)의 진단, 치료 및 관리와 관련된 제품 및 서비스가 포함됩니다. 이 시장에는 이환된 개의 증상을 완화하고 삶의 질을 향상시키기 위한 다양한 치료법과 치료법이 포함됩니다. 반려동물 먹이 제조업자 협회(PFMA)의 최근 자료에 따르면, 영국에서는 2022년에 3,490만 마리의 반려동물이 사육되었고, 그 중 1,300만 마리가 개로 예상되었습니다. 이러한 반려동물 인구 증가는 수의학적인 진료에 대한 수요 증가를 뒷받침하며, 이는 수의 전문가의 피부과 질환에 대한 전문화를 촉진하고 종합적인 반려동물 건강 관리 서비스에 대한 관심 증가를 돋보이게합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
9억 9,560만 달러
시장 규모 : 2030년
17억 4,047만 달러
CAGR : 2025-2030년
9.90%
급성장 부문
글루코 코르티코이드
최대 시장
북미
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향 :
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 개 아토피 피부염 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품별(글루코코르티코이드, 항히스타민제, 면역억제제, 단클론항체, 기타)
투여 방법별(국소, 경구, 주사)
유통 채널별(동물 병원 및 클리닉, 소매점, 전자상거래)
지역별
기업별(2024년)
제품 시장 맵
제품별
투여 방법별
유통 채널별
지역별
제6장 북미의 개 아토피 피부염 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 개 아토피 피부염 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
영국
프랑스
이탈리아
스페인
제8장 아시아태평양의 개 아토피 피부염 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
일본
인도
호주
한국
제9장 남미의 개 아토피 피부염 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 개 아토피 피부염 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
쿠웨이트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Zoetis Inc
Elanco Animal Health Inc
Virbac SA
Toray Industries Inc
AB Science SA
Boehringer Ingelheim GmbH
Kindred Biosciences Inc
제15장 전략적 제안
제16장 기업 소개와 면책사항
SHW
영문 목차
영문목차
The global Canine Atopic Dermatitis Market was valued at USD 995.60 million in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 9.90% from 2024 to 2030. This market encompasses products and services related to the diagnosis, treatment, and management of atopic dermatitis in dogs-a common skin condition that causes itching, inflammation, and discomfort. The market includes various therapies and treatments aimed at alleviating symptoms and improving the quality of life for affected dogs. According to recent data from the Pet Food Manufacturers' Association (PFMA), the United Kingdom was expected to have 34.9 million pets in 2022, including 13 million dogs. This rising pet population underscores the increasing demand for advanced veterinary care, which has driven the specialization of veterinary professionals in dermatological conditions, highlighting the growing focus on comprehensive pet healthcare services.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 995.60 Million
Market Size 2030
USD 1740.47 Million
CAGR 2025-2030
9.90%
Fastest Growing Segment
Glucocorticoids
Largest Market
North America
Key Market Drivers:
Rising Pet Ownership and Humanization: The global pet industry has seen significant growth, largely due to an increasing number of pet owners worldwide. Along with this trend, pets are increasingly being regarded as family members rather than just companions, a shift that has major implications for various pet-related markets, including the canine atopic dermatitis market. The 2021-2022 American Pet Products Association (APPA) National Pet Owners Survey revealed that dog owners spent an average of USD 458 on surgical veterinary visits and USD 242 on routine visits. This growing investment in pet health, combined with increasing awareness of canine health issues, is driving demand for advanced treatments, including those for conditions such as canine allergic dermatitis, thereby fostering growth in the veterinary care market. In particular, the rise in pet ownership has led to increased demand for healthcare products and services, including treatments for chronic conditions like atopic dermatitis. As pets are increasingly seen as family members, pet owners are more likely to prioritize high-quality healthcare, including preventive measures and ongoing management of conditions such as canine atopic dermatitis.
Key Market Challenges:
Misdiagnosis and Underdiagnosis: A key challenge in managing canine atopic dermatitis is the potential for misdiagnosis or underdiagnosis. Symptoms such as itching, redness, and skin irritation often overlap with other skin conditions, making accurate diagnosis essential. Failing to identify atopic dermatitis can result in improper treatments or a lack of intervention, potentially worsening the dog's condition.
Varied Triggers: Canine atopic dermatitis has various triggers, including environmental allergens, food sensitivities, and genetic factors. Identifying the specific trigger for each dog can be challenging, which makes developing a universal treatment plan difficult. This variability requires a personalized approach to treatment and care.
Compliance and Duration of Treatment: Ensuring compliance with prescribed treatment regimens over the long term can be a challenge for both pet owners and veterinarians. The ongoing nature of the condition necessitates sustained management, which may impact adherence to prescribed therapies.
Key Market Trends:
Advancements in Immunotherapy: Allergen-specific immunotherapy (ASIT) is becoming more refined and accessible. The development of more accurate allergy testing methods and innovative ASIT treatments is expected to enhance the management of atopic dermatitis by targeting the specific allergens that cause the condition in each dog.
Targeted Therapies: Pharmaceutical advancements are leading to the development of targeted therapies that address the underlying causes of canine atopic dermatitis. These treatments aim to reduce the need for long-term symptom management, ultimately improving the quality of life for affected dogs.
Holistic and Alternative Therapies: Holistic and alternative treatments, such as acupuncture, herbal remedies, and physical rehabilitation, are gaining popularity as complementary options for managing atopic dermatitis. These approaches are being recognized for their potential to improve overall well-being and provide additional management options for pet owners seeking non-traditional therapies.
Key Market Players:
Zoetis Inc.
Elanco Animal Health Inc.
Virbac SA
Toray Industries Inc.
AB Science SA
Boehringer Ingelheim GmbH
Kindred Biosciences Inc.
Report Scope:
This report segments the global Canine Atopic Dermatitis Market into multiple categories, providing valuable insights into industry trends and forecasts. The market is segmented as follows:
By Product:
Glucocorticoids
Antihistamines
Immunosuppressants
Monoclonal Antibodies (MAbs)
Others
By Mode of Administration:
Topical
Oral
Injectable
By Distribution Channel:
Veterinary Hospitals/Clinics
Retail
E-commerce
By Region:
North America: United States, Canada, Mexico
Europe: Germany, United Kingdom, France, Italy, Spain
Asia-Pacific: China, Japan, India, Australia, South Korea
South America: Brazil, Argentina, Colombia
Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait
Competitive Landscape:
This section offers a detailed analysis of the major players operating in the global Canine Atopic Dermatitis Market.
Available Customizations:
TechSci Research provides customization options for this market report based on specific company requirements. Customization options include detailed profiles of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Canine Atopic Dermatitis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
5.2.2. By Mode of Administration (Topical, Oral, Injectable)
5.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Mode of Administration
5.3.3. By Distribution Channel
5.3.4. By Region
6. North America Canine Atopic Dermatitis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
6.2.2. By Mode of Administration (Topical, Oral, Injectable)
6.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Canine Atopic Dermatitis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Canine Atopic Dermatitis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Canine Atopic Dermatitis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. Europe Canine Atopic Dermatitis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
7.2.2. By Mode of Administration (Topical, Oral, Injectable)
7.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Canine Atopic Dermatitis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Canine Atopic Dermatitis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. France Canine Atopic Dermatitis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Canine Atopic Dermatitis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Canine Atopic Dermatitis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Canine Atopic Dermatitis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
8.2.2. By Mode of Administration (Topical, Oral, Injectable)
8.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Canine Atopic Dermatitis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. Japan Canine Atopic Dermatitis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. India Canine Atopic Dermatitis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Australia Canine Atopic Dermatitis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. South Korea Canine Atopic Dermatitis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. South America Canine Atopic Dermatitis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
9.2.2. By Mode of Administration (Topical, Oral, Injectable)
9.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Canine Atopic Dermatitis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Canine Atopic Dermatitis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Canine Atopic Dermatitis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Canine Atopic Dermatitis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
10.2.2. By Mode of Administration (Topical, Oral, Injectable)
10.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Canine Atopic Dermatitis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Canine Atopic Dermatitis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Mode of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Canine Atopic Dermatitis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Mode of Administration
10.3.3.2.3. By Distribution Channel
10.3.4. Kuwait Canine Atopic Dermatitis Market Outlook
